Skip to main content
An official website of the United States government

Toxicology and Pharmacology Branch (TPB)

PK Graph

Toxicology and Pharmacology Branch (TPB)

Preclinical toxicology and pharmacology are required for decision making throughout drug discovery and development and for IND filing for clinical trials. Toxicological and pharmacological data can inform clinical trial design, such as determination of maximum tolerated dose, dose-limiting toxicities, and starting dose. With appropriate characterization, in most cases, safe operating parameters can be established for human clinical trials.

Ultimate Goal

The ultimate goal is to identify and characterize the toxicologic profile and pharmacokinetic properties of potential drug candidates and to support an Investigational New Agent Application (IND) or a Drug Master File (DMF) with the USFDA.

Drug Discovery and Development Process

Exploratory Screen Development →Screening/Designed Synthesis →Lead Development →Candidate Seeking →Clinical Candidate

SEE TPB RESOURCES and List of TPB Supported INDs

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Toxicology and Pharmacology Branch (TPB) was originally published by the National Cancer Institute.”

Email